Efficacy of aluminum chloride in severe regorafenib-associated hand-foot skin reactions: a single-arm trial
Abstract Background Regorafenib, a multikinase inhibitor, causes a high frequency of hand-foot skin reactions (HFSRs). The present study evaluated the efficacy of topical aluminum chloride, a perspiration suppressant, in reducing the severity of hand-foot skin reactions (HFSRs) caused by regorafenib...
Main Authors: | Aya Nishizawa, Eiji Shinozaki, Takeru Wakatsuki, Takahiro Satoh, Naoya Yamazaki, Shunsuke Oyamada, Keisuke Ariyoshi, Kota Kihara, Masahiro Tsuboi, Kensei Yamaguchi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-023-10864-9 |
Similar Items
-
The use of regorafenib in colorectal cancer
by: Marina I Sekacheva, et al.
Published: (2019-06-01) -
Factors Associated With Regorafenib Adherence With Metastatic Colorectal Cancer
by: Kawakami K, et al.
Published: (2019-10-01) -
Osteosarcoma of rib treated with regorafenib: a case report
by: Cemre Uçaryılmaz, et al.
Published: (2021-03-01) -
Case Report: Should Regorafenib be prescribed as a continuous schedule in gastrointestinal stromal tumors? Three case reports on Regorafenib personalized schedule
by: Maria Susanna Grimaudo, et al.
Published: (2023-05-01) -
Synergistic antitumor activity of regorafenib and rosuvastatin in colorectal cancer
by: Tao Yuan, et al.
Published: (2023-04-01)